跳至主要内容
临床试验/NCT00993005
NCT00993005已完成3 期

Efficacy of CICATRIX (Asian Gotu Kola or Pennywort) in the Treatment of Hypertrophic Scars and Keloids Scars.

Catalysis SL2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Catalysis SL
入组人数
90
试验地点
2
主要终点
Length of the hypertrophic scar(s) and keloids measured by a millimetric ruler at week 12 (end of the treatment)

研究概览

简要总结

The purpose of the study is to assess the efficacy of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of Hypertrophic scars and keloids. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 90.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Hypertrophic wound or keloid with no treatment for more than 1 month.
  • Signed informed consent.

排除标准

  • Usage of steroids within 30 days.
  • Malignant neoplastic conditions.
  • Alcoholism.
  • Handicap and/or psychiatric condition preventing treatment accomplishment.

结局指标

主要结局

Length of the hypertrophic scar(s) and keloids measured by a millimetric ruler at week 12 (end of the treatment)

时间窗: 12 weeks

次要结局

  • Occurrence of adverse effects at week 12 (end of the treatment)(12 weeks)
  • Photographs of lesions at week 12 (end of the treatment)(12 weeks)

研究者

发起方
Catalysis SL
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验